DNA Methylation Technologies: Existing Challenges and New Opportunities

Ann Arbor MI 01-16-2020 01-16-2020

Epigenetic modifications are important drivers of development, health, and disease. DNA methylation is one type of epigenetic mark that can be measured in blood or other human samples. DNA methylation marks are associated with genetics and environmental exposures, which represents a useful tool for public health and medicine. This Taubman Technology Talk will give an overview of current technologies for DNA methylation measurements, describe methodological challenges associated with these methods, and provide evidence-based opportunities for future DNA methylation studies. Presenter Kelly M. Bakulski, Ph.D, is an Assistant Professor in the Department of Epidemiology at the University of Michigan School of Public Health. Dr. Bakulski’s research goal is to understand the environmental and genetic etiologies of neurological disorders, including autism spectrum disorder and Alzheimer’s disease. Dr. Bakulski incorporates population approaches and laboratory experiments to develop biomarker and cell type tools to better inform epigenetic inferences. Please join us for the lecture and Q&A, followed by pizza. No charge, but registration is appreciated to assist with catering estimates. Click here for the Eventbrite portal. CME Credit is available to physicians.

By Kelly Bakulski, PhD for Taubman Technology Talks

January 16, 2020
5:00 pm - 6:00 pm
Danto Auditorium at Frankel Cardiovascular Center
Sponsored by: Taubman Institute
Contact Information: Melissa Preddy mpreddy@med.umich.edu (734) 218-2043

More Information & Registration

Epigenetic modifications are important drivers of development, health, and disease. DNA methylation is one type of epigenetic mark that can be measured in blood or other human samples. DNA methylation marks are associated with genetics and environmental exposures, which represents a useful tool for public health and medicine. This Taubman Technology Talk will give an overview of current technologies for DNA methylation measurements, describe methodological challenges associated with these methods, and provide evidence-based opportunities for future DNA methylation studies. Presenter Kelly M. Bakulski, Ph.D, is an Assistant Professor in the Department of Epidemiology at the University of Michigan School of Public Health. Dr. Bakulski’s research goal is to understand the environmental and genetic etiologies of neurological disorders, including autism spectrum disorder and Alzheimer’s disease. Dr. Bakulski incorporates population approaches and laboratory experiments to develop biomarker and cell type tools to better inform epigenetic inferences. Please join us for the lecture and Q&A, followed by pizza. No charge, but registration is appreciated to assist with catering estimates. Click here for the Eventbrite portal. CME Credit is available to physicians.

Event Flyer for DNA Methylation Technologies: Existing Challenges and New Opportunities